Svetel M, Djarmati A, Dragasević N, Savić D, Culjković B, Romac S, Kostić V S
Institute of Neurology CCS, School of Medicine, University of Belgrade, Belgrade, Serbia.
Eur J Neurol. 2003 Sep;10(5):597. doi: 10.1046/j.1468-1331.2003.00671.x.
In this study no one of our 85 patients of Serbian origin with young-onset (</= 45 years) dopa-responsive parkinsonism (YOP), previously proved negative for PARK1 and PARK2 mutations, had either spinocerebellar ataxia type 2 (SCA2) or SCA3 mutation. These data do not prove the significance of these two mutations in either sporadic or familial YOP suggestive of Parkinson's disease.
